Table 5 Summary of prevalence across and over all sites
From: FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
| Â | Â | Â | Gray | Pre | ||
|---|---|---|---|---|---|---|
Site | Gender | Total | N | Prevalence | N | Prevalence |
CH | F | 3,140 | 45 | 1 : 70 | 12 | 1 : 262 |
| Â | M | 3,279 | 25 | 1 : 131 | 4 | 1 : 820 |
NC | F | 1,754 | 29 | 1 : 60 | 11 | 1 : 159 |
| Â | M | 1,861 | 23 | 1 : 81 | 4 | 1 : 465 |
SAC | F | 1,995 | 31 | 1 : 64 | 10 | 1 : 200 |
| Â | M | 2,150 | 17 | 1 : 126 | 9 | 1 : 239 |
Overall | F | 6,889 | 105 | 1:66 | 33 | 1:209 |
| Â | M | 7,290 | 65 | 1:112 | 17 | 1:430 |